Cesca files suit over patent application

• Cesca Therapeutics (NASDAQ:KOOL) files suit in the U.S. District Court, Eastern District of California against SynGen et al. (Case No. 2:14-cv-02085-GEB-KJN) alleging the SynGenX-1000 and the patent application "System for Purifying Certain Cell Populations in Blood or Bone Marrow by Depleting Others" were developed using Cesca confidential information and that Cesca is the equitable owner. Cesca accuses the defendants of misappropriation of trade secrets, breach of contract and other claims.
• Cesca plans to update shareholders on the progress of the suit via its 10-Q filings.